Baldwin RL - Search Results

1

Altered expression of transforming growth factor-beta ligands and receptors in primary and recurrent ovarian carcinoma.

Bristow RE, Baldwin RL, Yamada SD, Korc M, Karlan BY. Bristow RE, et al. Among authors: baldwin rl. Cancer. 1999 Feb 1;85(3):658-68. doi: 10.1002/(sici)1097-0142(19990201)85:3<658::aid-cncr16>3.0.co;2-m. Cancer. 1999. PMID: 10091739

2

Loss of c-myc repression coincides with ovarian cancer resistance to transforming growth factor beta growth arrest independent of transforming growth factor beta/Smad signaling.

Baldwin RL, Tran H, Karlan BY. Baldwin RL, et al. Cancer Res. 2003 Mar 15;63(6):1413-9. Cancer Res. 2003. PMID: 12649207

3

Improved survival in women with BRCA-associated ovarian carcinoma.

Cass I, Baldwin RL, Varkey T, Moslehi R, Narod SA, Karlan BY. Cass I, et al. Among authors: baldwin rl. Cancer. 2003 May 1;97(9):2187-95. doi: 10.1002/cncr.11310. Cancer. 2003. PMID: 12712470 Free article.

4

Estrogen and progesterone receptor subtype expression in normal and malignant ovarian epithelial cell cultures.

Li AJ, Baldwin RL, Karlan BY. Li AJ, et al. Among authors: baldwin rl. Am J Obstet Gynecol. 2003 Jul;189(1):22-7. doi: 10.1067/mob.2003.328. Am J Obstet Gynecol. 2003. PMID: 12861133

5

Short androgen receptor allele length is a poor prognostic factor in epithelial ovarian carcinoma.

Li AJ, Baldwin RL, Karlan BY. Li AJ, et al. Among authors: baldwin rl. Clin Cancer Res. 2003 Sep 1;9(10 Pt 1):3667-73. Clin Cancer Res. 2003. PMID: 14506156

6

Primary ovarian cancer cultures are resistant to Fas-mediated apoptosis.

Baldwin RL, Tran H, Karlan BY. Baldwin RL, et al. Gynecol Oncol. 1999 Aug;74(2):265-71. doi: 10.1006/gyno.1999.5448. Gynecol Oncol. 1999. PMID: 10419743

7

Ovarian carcinoma cell cultures are resistant to TGF-beta1-mediated growth inhibition despite expression of functional receptors.

Yamada SD, Baldwin RL, Karlan BY. Yamada SD, et al. Among authors: baldwin rl. Gynecol Oncol. 1999 Oct;75(1):72-7. doi: 10.1006/gyno.1999.5535. Gynecol Oncol. 1999. PMID: 10502429

8

BRCA1 promoter region hypermethylation in ovarian carcinoma: a population-based study.

Baldwin RL, Nemeth E, Tran H, Shvartsman H, Cass I, Narod S, Karlan BY. Baldwin RL, et al. Cancer Res. 2000 Oct 1;60(19):5329-33. Cancer Res. 2000. PMID: 11034065

9

Differential gene expression between normal and tumor-derived ovarian epithelial cells.

Ismail RS, Baldwin RL, Fang J, Browning D, Karlan BY, Gasson JC, Chang DD. Ismail RS, et al. Among authors: baldwin rl. Cancer Res. 2000 Dec 1;60(23):6744-9. Cancer Res. 2000. PMID: 11118061

10

Molecular similarities between primary peritoneal and primary ovarian carcinomas.

Chen LM, Yamada SD, Fu YS, Baldwin RL, Karlan BY. Chen LM, et al. Among authors: baldwin rl. Int J Gynecol Cancer. 2003 Nov-Dec;13(6):749-55. doi: 10.1111/j.1525-1438.2003.13605.x. Int J Gynecol Cancer. 2003. PMID: 14675310

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

518 results

Search Page

Filters